This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
Julie Vickers
Advertisement
Julie Vickers is a subject matter expert in Process Engineering at Jacobs.
Articles by Julie Vickers
Advertisement
Latest Updated Articles
Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine ManufacturingPublished: August 3rd 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
PharmTech Weekly News Roundup — Week of October 27, 2025
4
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
5
